(Q72893436)

English

Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial. Kobe University Urological Oncology Group

scientific article published on 01 January 1994

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial. Kobe University Urological Oncology Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H Eto

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Y Oka

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

K Ueno

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

I Nakamura

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

K Yoshimura

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S Arakawa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S Kamidono

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S Obe

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

T Ogawa

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

G Hamami

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

35 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S46-51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BCG in carcinoma in situ and superficial bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biology and treatment of superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 1/2 study of intravesical epirubicin in patients with carcinoma in situ of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status of intravesical chemotherapy trials in the EORTC Urological Group. An overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical chemoresection with 4'-epi-doxorubicin in patients with superficial bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multi-centre phase II study of low dose intravesical epirubicin in the treatment of superficial bladder cancer. Yorkshire and Scottish Urological Cancer Research Groups.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Intravesical chemotherapy with 4'-Epi-Adriamycin in patients with superficial bladder tumors]

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary ca

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical chemotherapy with 4'-epi-Adriamycin in patients with superficial bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of intravesical instillation of antitumor chemotherapeutic agents on bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant Chemotherapy of Recurrent Superficial Transitional Cell Carcinoma: Results of a European Organization for Research on Treatment of Cancer Randomized Trial Comparing Intravesical Instillation of Thiotepa, Doxorubicin and Cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter study of superficial bladder cancer treated with intravesical bacillus Calmette-Guerin or adriamycin. Results of long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical Instillations of 4-EPI-Doxorubicin (Epirubicin) in the Prophylactic Treatment of Superficial Bladder Cancer: Results of a Controlled Prospective Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical evaluation of 4'-epi-doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00686919

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994786%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72893436&oldid=2219754712"